Literature DB >> 8872139

Interleukin-1 alpha induces variations of the intranuclear amount of phosphatidylinositol 4,5-bisphosphate and phospholipase C beta 1 in human osteosarcoma Saos-2 cells.

N Zini1, P Sabatelli, I Faenza, A Ognibene, N M Maraldi.   

Abstract

Some key elements of signal transduction have been identified within the nucleus and demonstrated to be responsive to specific agonists in numerous cell types. In particular, mitogenic stimuli have been reported to induce a transient increase of the nuclear phospholipase C beta 1 activity, causing the release of inositide-derived second messengers, whereas differentiating stimuli induced a decrease of the enzyme activity and an increase of nuclear phosphatidylinositol 4,5-bisphosphate (PIP2). Recently, we reported evidence, in human osteosarcoma Saos-2 cell lines, on the presence of specific nuclear phospholipase C isoforms and on the activation of phospholipase C beta 1 in the nucleus following the exposure to interleukin-1 alpha. In this study we report immunocytochemical ultrastructural evidence on quantitative variations of PIP2 and phospholipase C beta 1 amounts in the nucleus of Saos-2 cells at different times of exposure to interleukin-1 alpha. After short periods of culture in the presence of the agonist, the intranuclear amount of PIP2 is decreased, while a translocation of phospholipase C beta 1 occurs from the cytoplasm to the nucleus, in correspondence with the increased hydrolyzing activity of the enzyme. After longer periods of incubation with interleukin-1 alpha, on the other hand, the intranuclear amount of PIP2 is restored to initial level, while the amount of phospholipase C beta 1 is increased both at the nuclear and cytoplasmic level, when its activation is no longer effective. The results, compared with those obtained in other cell types responsive to given agonists, account for a cell-specific modulation of signal transduction based on polyphosphoinositide breakdown at the nuclear level.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8872139     DOI: 10.1007/bf02331409

Source DB:  PubMed          Journal:  Histochem J        ISSN: 0018-2214


  34 in total

1.  Nuclear PIPs.

Authors:  R H Michell
Journal:  Curr Biol       Date:  1992-04       Impact factor: 10.834

2.  Intracellular location of the histonelike protein HU in Escherichia coli.

Authors:  M Dürrenberger; M A Bjornsti; T Uetz; J A Hobot; E Kellenberger
Journal:  J Bacteriol       Date:  1988-10       Impact factor: 3.490

3.  Internalization and nuclear localization of interleukin 1 are not sufficient for function.

Authors:  A Heguy; C Baldari; K Bush; R Nagele; R C Newton; R J Robb; R Horuk; J L Telford; M Melli
Journal:  Cell Growth Differ       Date:  1991-07

4.  Immunocytochemical detection of the intranuclear variations of phosphatidylinositol 4,5-bisphosphate amount associated with changes of activity and amount of phospholipase C beta 1 in cells exposed to mitogenic or differentiating agonists.

Authors:  N M Maraldi; N Zini; A Ognibene; A M Martelli; M Barbieri; G Mazzotti; F A Manzoli
Journal:  Biol Cell       Date:  1995       Impact factor: 4.458

5.  Phosphoinositide signaling in nuclei of Friend cells: phospholipase C beta down-regulation is related to cell differentiation.

Authors:  A M Martelli; A M Billi; R S Gilmour; L M Neri; L Manzoli; A Ognibene; L Cocco
Journal:  Cancer Res       Date:  1994-05-15       Impact factor: 12.701

6.  Nuclear diacylglycerol is increased during cell proliferation in vivo.

Authors:  H Banfić; M Zizak; N Divecha; R F Irvine
Journal:  Biochem J       Date:  1993-03-15       Impact factor: 3.857

7.  Identification of a polyphosphoinositide-binding sequence in an actin monomer-binding domain of gelsolin.

Authors:  F X Yu; H Q Sun; P A Janmey; H L Yin
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

8.  Relationship of cAMP and calcium messenger systems in prostaglandin-stimulated UMR-106 cells.

Authors:  D T Yamaguchi; T J Hahn; T G Beeker; C R Kleeman; S Muallem
Journal:  J Biol Chem       Date:  1988-08-05       Impact factor: 5.157

9.  Phosphoinositidase C isozymes in SaOS-2 cells: immunocytochemical detection in nuclear and cytoplasmic compartments.

Authors:  N M Maraldi; N Zini; S Santi; A Bavelloni; A Valmori; S Marmiroli; A Ognibene
Journal:  Biol Cell       Date:  1993       Impact factor: 4.458

Review 10.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

View more
  5 in total

Review 1.  Lessons from in vitro studies and a related intracellular angiotensin II transgenic mouse model.

Authors:  Julia L Cook; Richard N Re
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-12-14       Impact factor: 3.619

2.  Cytoplasmic and nuclear phospholipase C-beta 1 relocation: role in resumption of meiosis in the mouse oocyte.

Authors:  N Avazeri; A M Courtot; A Pesty; C Duquenne; B Lefèvre
Journal:  Mol Biol Cell       Date:  2000-12       Impact factor: 4.138

3.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

4.  IL1-beta and TNF-alpha induce changes in the nuclear polyphosphoinositide signalling system in osteoblasts similar to that occurring in patients with rheumatoid arthritis: an immunochemical and immunocytochemical study.

Authors:  Nicoletta Zini; Gina Lisignoli; Liliana Solimando; Alberto Bavelloni; Francesco Grassi; Lia Guidotti; Carmela Trimarchi; Andrea Facchini; Nadir Mario Maraldi
Journal:  Histochem Cell Biol       Date:  2003-08-12       Impact factor: 4.304

5.  Phosphoinositide signaling pathways in nuclei are associated with nuclear speckles containing pre-mRNA processing factors.

Authors:  I V Boronenkov; J C Loijens; M Umeda; R A Anderson
Journal:  Mol Biol Cell       Date:  1998-12       Impact factor: 4.138

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.